Results for keyword - Gynecologic Malignancy | PennyOmega.com

Entries (RSS)

Categories

Tag Cloud
Advertise with Penny Omega
Penny Omega Vision
Penny Omega Newsletter
Market Blogs
Powered By Ringsurf
Blog Directory
Rochester job

FDA Awarded Aeterna Zentaris (AEZS) Special Protocol Assessment for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108

Tags: AEterna Zentaris, AEZS, endometrial cancer, gynecologic malignancy, Nasdaq:AEZS

Dec 28th, 2012

Video
Hot stocks to watch!

Microsoft Corporation - MSFT
Direxion Shs Etf Tr - FAZ
Bucyrus International Inc - BUCY
ProShares UltraShort S&P500 ETF - SDS
Symantec Corp - SYMC
iShares MSCI EAFE Index ETF - EFA
QUALLCOMM Inc - QCOM
Wells Fargo & Co - WFC
News Corp - NWSA
Select Sector SPDR: Industrial Sector Fund - XLI
Popular Inc - BPOP
Nokia Corp - NOK
PowerShares QQQ - QQQQ
Oracle Corporation - ORCL
Advanced Micro Devices - AMD
iShares FTSE/Xinhua China 25 - FXI
Urban Outfitters Inc - URBN
Fifth Third Bancorp - FITB
Altera Corp - ALTR
Crown Equity Holdings Inc. - CRWE.OB
Cleantech Transit, Inc. - CLNO.OB
JA Solar Holdings Co Ltd - JASO

Copyright © 2013 PennyOmega.com

Disclaimer: Information contained on this page is provided by companies featured through PennyOmega.com and this Station cannot confirm the accuracy of this information and make no warranties or representations in connection therewith. Therefore, PennyOmega.com is not liable for the contents, errors or delays in contents, information on their company website, or any actions taken in reliance thereon.The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site nor do they represent the views or opinions of the Crown Equity Holdings Inc. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. For more information click HERE.